Interview with Mivium CEO, Eric Tsai
Earlier this week we sat down with the CEO of Mivium, Eric Tsai, a semiconductor material science company developing proprietary technology to produce high-purity gallium
This guide is brought to you by Equifund, LLC.
If you have money saved in a retirement account – like 401k, 403b, IRA, or Roth IRA – your investment options are likely restricted to things like stocks, bonds, and mutual funds.
But according to ProPublica, wealthy Americans have been using their retirement accounts to invest in Pre-IPO investments to create a tax advantaged fortune!
The most notable example being the founder of PayPal – and now billionaire venture capitalist – Peter Thiel.
According to the same ProPublica article Thiel started a Roth IRA in 1999 with assets that at the time were worth less than $2,000. Those assets are now valued at $5 billion.
How did he do it?
It all has to do with this little-known account that “unlocks” your retirement assets.
For the full details, read our free guide called Pre-IPO Retirement Accounts: How to Invest in Pre-IPO Investments With a Self-Directed IRA
Yours for investing equality,
Jordan Gillissie – CEO
Equifund
Earlier this week we sat down with the CEO of Mivium, Eric Tsai, a semiconductor material science company developing proprietary technology to produce high-purity gallium
This webinar is designed to help you understand and answer one of the most important questions a pre-IPO investor has to answer: “what do I do once the company goes public?”
Kleiner Device Labs hopes to revolutionize spinal surgery with its breakthrough technology. Today, we sat down with its Founder and CEO Dr. Je
In this webinar our CEO, Jordan Gillissie, and our Publisher, Jake Hoffberg, sit down to discuss Equifund’s 2025 Market Outlook. During this call we discuss:
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
Notifications